Investments
Dec. 9, 2003
Saegis Bolsters Drug Research With $30 Million
Venture capitalists have poured $30 million into Saegis Pharmaceuticals Inc., bolstering its efforts to develop new drugs to improve brain function.
The company, based in Half Moon Bay, will use the new funds to support clinical trials of drugs to treat Alzheimer's disease and schizophrenia. Saegis received legal cou...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In